Sale!

DNAH11 Gene Primary Ciliary Dyskinesia Type 7 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The DNAH11 Gene Primary Ciliary Dyskinesia Type 7 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the DNAH11 gene that are associated with Primary Ciliary Dyskinesia (PCD) Type 7. This condition is a rare genetic disorder characterized by chronic respiratory tract infections, abnormal organ positioning, and fertility issues, arising from defects in the structure and function of cilia, which are tiny, hair-like structures that line the airways, reproductive system, and other parts of the body.

The test, priced at 4400 AED, involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab. The sample is then analyzed in the laboratory using advanced genetic sequencing techniques to detect any mutations in the DNAH11 gene that are known to cause PCD Type 7. This precise genetic testing allows for an accurate diagnosis of the condition, enabling targeted treatment and management strategies to improve the quality of life for affected individuals.

DNA Labs UAE is recognized for its state-of-the-art facilities and expert team of geneticists and laboratory technicians, ensuring high-quality testing and reliable results for patients and their families. The availability of such a test represents a significant step forward in the diagnosis and understanding of Primary Ciliary Dyskinesia, offering hope for better management of this challenging condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

DNAH11 Gene Primary ciliary dyskinesia type 7 Genetic Test

At DNA Labs UAE, we offer the DNAH11 Gene Primary ciliary dyskinesia type 7 Genetic Test for individuals who suspect they may have this genetic disorder. This test is designed to analyze the DNAH11 gene, which is associated with primary ciliary dyskinesia type 7 (PCD7).

Test Components

The DNAH11 Gene Primary ciliary dyskinesia type 7 Genetic Test includes the following components:

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Ear Nose Throat Disorders
  • Doctor: ENT Doctor
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the DNAH11 Gene Primary ciliary dyskinesia type 7 Genetic Test, it is important to provide the clinical history of the patient. In this case, the patient is going for the GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test. Additionally, a Genetic Counselling session is required to draw a pedigree chart of family members affected with GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test gene GJB19.

Test Details

The DNAH11 gene is associated with a genetic disorder called primary ciliary dyskinesia type 7 (PCD7). PCD is a rare genetic condition characterized by abnormal movement of cilia, which are hair-like structures that line the respiratory tract, sinuses, and other organs.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes. In the case of PCD7, NGS genetic testing can identify mutations or variations in the DNAH11 gene that may be responsible for the development of the disorder.

This type of genetic testing can help in the diagnosis of PCD7, as well as provide information about the specific genetic variants present in an individual. This information can be useful for understanding the underlying cause of the condition, predicting disease progression, and informing treatment options.

Test Name DNAH11 Gene Primary ciliary dyskinesia type 7 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test gene GJB19
Test Details

The DNAH11 gene is associated with a genetic disorder called primary ciliary dyskinesia type 7 (PCD7). PCD is a rare genetic condition characterized by abnormal movement of cilia, which are hair-like structures that line the respiratory tract, sinuses, and other organs.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes. In the case of PCD7, NGS genetic testing can identify mutations or variations in the DNAH11 gene that may be responsible for the development of the disorder.

This type of genetic testing can help in the diagnosis of PCD7, as well as provide information about the specific genetic variants present in an individual. This information can be useful for understanding the underlying cause of the condition, predicting disease progression, and informing treatment options.